Skip to main content

Table 6 Demographic, clinical and biochemical parameters among recurrent and eradicated HCC cases

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter Recurrent HCC cases (n=6) Eradicated HCC cases (n=30) p
Age (years) 62.8±3.1 56 ±6.9 < 0.001
BMI (Kg/m2) 24.5±1.6 24.7±2.3 0.869
Gender Male n (%) 5 (83.3) 20 (66.7) 0.643a
Female n (%) 1 (16.7) 10 (33.3)
Child-Pugh score 7.2±0.8 5.9±1.0 0.008
ALT (U/L) 67.8±38.9 54.3±26.2 0.295
AST (U/L) 62.8±41.4 56.8±29.5 0.672
ALP (U/L) 80.0±24.5 79.5±24.7 0.964
S. albumin (g/dl) 3.3±0.2 3.7±0.4 0.036
T. bilirubin (mg/dl) 1.7±0.5 1.5±0.4 0.198
D. bilirubin (mg/dl) 0.8±0.2 0.7±0.2 0.119
INR 1.6±0.4 1.3±0.4 0.118
Hemoglobin (g/dL) 9.6±1.9 10.2±1.4 0.358
WBCs (× 103/mL) 4.2±2.4 5.3±2.3 0.301
Platelets (× 103/mL) 159.2±21.6 146.2±37.4 0.42
S. creatinine (mg/dL) 0.92±0.33 0.84±0.34 0.598
S. sodium (mEq/L) 137.3±4.1 137.5±3.7 0.907
S. potassium (mEq/L) 4.1±0.7 4.0±0.5 0.841
Number of HCC lesions 3.0±0.0 1.7±0.7 < 0.001
Size of HCC lesions (cm) 6.2±1.6 3.3±1.2 < 0.001
  1. aFisher’s exact test